Assisted differential network analysis for gene expression data

2021 ◽  
Author(s):  
Huangdi Yi ◽  
Shuangge Ma
Keyword(s):  
Gene Expression ◽  
Network Analysis ◽  
Gene Expression Data ◽  
Expression Data ◽  
Differential Network Analysis ◽  
Differential Network

PAGeneRN

2020 ◽  
pp. 1052-1075 ◽  
Author(s):  
Dina Elsayad ◽  
A. Ali ◽  
Howida A. Shedeed ◽  
Mohamed F. Tolba
Keyword(s):  
Gene Expression ◽  
Data Analysis ◽  
Network Analysis ◽  
Gene Regulatory Network ◽  
Gene Expression Data ◽  
Regulatory Network ◽  
Regulatory Networks ◽  
Expression Data ◽  
Gene Expression Data Analysis ◽  
Gene Regulatory

The gene expression analysis is an important research area of Bioinformatics. The gene expression data analysis aims to understand the genes interacting phenomena, gene functionality and the genes mutations effect. The Gene regulatory network analysis is one of the gene expression data analysis tasks. Gene regulatory network aims to study the genes interactions topological organization. The regulatory network is critical for understanding the pathological phenotypes and the normal cell physiology. There are many researches that focus on gene regulatory network analysis but unfortunately some algorithms are affected by data size. Where, the algorithm runtime is proportional to the data size, therefore, some parallel algorithms are presented to enhance the algorithms runtime and efficiency. This work presents a background, mathematical models and comparisons about gene regulatory networks analysis different techniques. In addition, this work proposes Parallel Architecture for Gene Regulatory Network (PAGeneRN).

Defining Immune Response Signatures in DLBCL As Potential Predictive Biomarkers for Outcome to Immunotherapy

Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 2663-2663
Author(s):  
Matthew A Care ◽  
Stephen M Thirdborough ◽  
Andrew J Davies ◽  
Peter W.M. Johnson ◽  
Andrew Jack ◽  
...  
Keyword(s):  
Gene Expression ◽  
Immune Response ◽  
Network Analysis ◽  
Gene Expression Data ◽  
Research Funding ◽  
Data Sets ◽  
Expression Data ◽  
Data Set ◽  
Gene Correlation ◽  
Cancer Types

Abstract Purpose To assess whether comparative gene network analysis can reveal characteristic immune response signatures that predict clinical response in Diffuse large B-cell lymphoma (DLBCL). Background The wealth of available gene expression data sets for DLBCL and other cancer types provides a resource to define recurrent pathological processes at the level of gene expression and gene correlation neighbourhoods. This is of particular relevance in the context of cancer immune responses, where convergence onto common patterns may drive shared gene expression profiles. Where existing and novel immunotherapies harness the immune response for therapeutic benefit such responses may provide predictive biomarkers. Methods We independently analysed publically available DLBCL gene expression data sets and a wide compendium of gene expression data from diverse cancer types, and then asked whether common elements of cancer host response could be identified from resulting networks. Using 10 DLBCL gene expression data sets, encompassing 2030 cases, we established pairwise gene correlation matrices per data set, which were merged to generate median correlations of gene pairs across all data sets. Gene network analysis and unsupervised clustering was then applied to define global representations of DLBCL gene expression neighbourhoods. In parallel a diverse range of solid and lymphoid malignancies including; breast, colorectal, oesophageal, head and neck, non-small cell lung, prostate, pancreatic cancer, Hodgkin lymphoma, Follicular lymphoma and DLBCL were independently analysed using an orthogonal weighted gene correlation network analysis of gene expression data sets from which correlated modules across diverse cancer types were identified. The biology of resulting gene neighbourhoods was assessed by signature and ontology enrichment, and the overlap between gene correlation neighbourhoods and WGCNA derived modules associated with immune/host responses was analysed. Results Amongst DLBCL data, we identified distinct gene correlation neighbourhoods associated with the immune response. These included both elements of IFN-polarised responses, core T-cell, and cytotoxic signatures as well as distinct macrophage responses. Neighbourhoods linked to macrophages separated CD163 from CD68 and CD14. In the WGCNA analysis of diverse cancer types clusters corresponding to these immune response neighbourhoods were independently identified including a highly similar cluster related to CD163. The overlapping CD163 clusters in both analyses linked to diverse Fc-Receptors, complement pathway components and patterns of scavenger receptors potentially linked to alternative macrophage activation. The relationship between the CD163 macrophage gene expression cluster and outcome was tested in DLBCL data sets, identifying a poor response in CD163 -cluster high patients, which reached statistical significance in one data set (GSE10846). Notably, the effect of the CD163-associated gene neighbourhood which correlates with poor outcome post rituximab containing immunochemotherapy is distinct from the effect of IFNG-STAT1-IRF1 polarised cytotoxic responses. The latter represents the predominant immune response pattern separating cell of origin unclassifiable (Type-III) DLBCL from either ABC or GCB DLBCL subsets, and is associated with a trend toward positive outcome. Conclusion Comparative gene expression network analysis identifies common immune response signatures shared between DLBCL and other cancer types. Gene expression clusters linked to CD163 macrophage responses and IFNG-STAT1-IRF1 polarised cytotoxic responses are common patterns with apparent divergent outcome association. Disclosures Davies: CTI: Honoraria; GIlead: Consultancy, Honoraria, Research Funding; Mundipharma: Honoraria, Research Funding; Bayer: Research Funding; Takeda: Honoraria, Research Funding; Janssen: Honoraria, Research Funding; Roche: Honoraria, Research Funding; GSK: Research Funding; Pfizer: Honoraria; Celgene: Honoraria, Research Funding. Jack:Jannsen: Research Funding.

scholarly journals The Analysis of Gene Expression Data Incorporating Tumor Purity Information

2021 ◽  
Vol 12 ◽  
Author(s):  
Seungjun Ahn ◽  
Tyler Grimes ◽  
Somnath Datta
Keyword(s):  
Gene Expression ◽  
Tumor Cells ◽  
Gene Expression Data ◽  
The Cancer Genome Atlas ◽  
Data Sets ◽  
Expression Data ◽  
Tumor Purity ◽  
Robust Model ◽  
Differential Network ◽  
Cancer Genome Atlas

The tumor microenvironment is composed of tumor cells, stroma cells, immune cells, blood vessels, and other associated non-cancerous cells. Gene expression measurements on tumor samples are an average over cells in the microenvironment. However, research questions often seek answers about tumor cells rather than the surrounding non-tumor tissue. Previous studies have suggested that the tumor purity (TP)—the proportion of tumor cells in a solid tumor sample—has a confounding effect on differential expression (DE) analysis of high vs. low survival groups. We investigate three ways incorporating the TP information in the two statistical methods used for analyzing gene expression data, namely, differential network (DN) analysis and DE analysis. Analysis 1 ignores the TP information completely, Analysis 2 uses a truncated sample by removing the low TP samples, and Analysis 3 uses TP as a covariate in the underlying statistical models. We use three gene expression data sets related to three different cancers from the Cancer Genome Atlas (TCGA) for our investigation. The networks from Analysis 2 have greater amount of differential connectivity in the two networks than that from Analysis 1 in all three cancer datasets. Similarly, Analysis 1 identified more differentially expressed genes than Analysis 2. Results of DN and DE analyses using Analysis 3 were mostly consistent with those of Analysis 1 across three cancers. However, Analysis 3 identified additional cancer-related genes in both DN and DE analyses. Our findings suggest that using TP as a covariate in a linear model is appropriate for DE analysis, but a more robust model is needed for DN analysis. However, because true DN or DE patterns are not known for the empirical datasets, simulated datasets can be used to study the statistical properties of these methods in future studies.

scholarly journals Insights into TREM2 biology by network analysis of human brain gene expression data

2013 ◽  
Vol 34 (12) ◽  
pp. 2699-2714 ◽  
Author(s):  
Paola Forabosco ◽  
Adaikalavan Ramasamy ◽  
Daniah Trabzuni ◽  
Robert Walker ◽  
Colin Smith ◽  
...  
Keyword(s):  
Gene Expression ◽  
Network Analysis ◽  
Human Brain ◽  
Gene Expression Data ◽  
Expression Data ◽  
Brain Gene Expression
Sign in / Sign up

Export Citation Format

Share Document